Nathan Connell on the 1st von Willebrand Factor/Factor VIII Relevance Academy
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:
”We recently held the first von Willebrand Factor/Factor VIII Relevance Academy in Orlando, Florida.
It was a wonderful day of learning and discussion about so many topics of importance to the hemostasis community.
From basic science to clinical and epidemiologic applications, I was excited to see so much focus on improving the quality of life for those with inherited bleeding disorders.
I was asked to present on the role of VWF concentrate prophylaxis in people with von Willebrand disease.
We have more data now than we did when the international VWD guidelines were published in 2021.
Still, we continue to have so many questions about who would benefit the most and how to optimize our prophylaxis strategies.
Thank you to the always outstanding Octapharma team, including Stefano Carta, Belyanskaya Larisa, Claudio Sandoval, and many others, as well as Academy chair Robert Sidonio, and all the faculty and participants who contributed to the discussion.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria